EOD .0143. In 3 days market perception does a 180:
Post# of 36729
Posted On: 10/14/2013 4:55:09 PM
EOD .0143. In 3 days market perception does a 180: SKTO growth company. Early release of Q3 shows confidence.
"The Company had a terrific third quarter," said Kevin Allyn, Chairman of SK3 Group, Inc.
Compare that glowing term "terrific" to Allyn's almost tepid description of upcoming Q2 results in his July 2013 letter: "We are preparing to issue our Q2 2013 financials, which, as you will see, show that the company has continued its steady growth." (Keep in mind Q2 showed $13.7mil in revenues!)
The Q3 results could be eye-popping. Shorting this stock now is an act of insanity. Plain selling it now is perhaps one notch below that.
"When the financial results are released, investors will see that we continue in our long-term focus to collect receivables, enhance revenues, and increase cash on hand -- while investing intelligently in the business. We also continue to focus on personnel and acquiring the right business relationships, as we expand the Company's role in the medical marijuana space. We look forward to sharing more details with our investors on each of these points in the near future," said Allyn.
"The Company had a terrific third quarter," said Kevin Allyn, Chairman of SK3 Group, Inc.
Compare that glowing term "terrific" to Allyn's almost tepid description of upcoming Q2 results in his July 2013 letter: "We are preparing to issue our Q2 2013 financials, which, as you will see, show that the company has continued its steady growth." (Keep in mind Q2 showed $13.7mil in revenues!)
The Q3 results could be eye-popping. Shorting this stock now is an act of insanity. Plain selling it now is perhaps one notch below that.
"When the financial results are released, investors will see that we continue in our long-term focus to collect receivables, enhance revenues, and increase cash on hand -- while investing intelligently in the business. We also continue to focus on personnel and acquiring the right business relationships, as we expand the Company's role in the medical marijuana space. We look forward to sharing more details with our investors on each of these points in the near future," said Allyn.
(0)
(0)